Dermoscopy vs standard marking for skin cancer removal
Part of Cancer, Skin clinical trials.
This trial compares two ways of marking skin before removing a non-melanoma skin cancer: using a special magnifying tool called a dermoscope versus the standard method. The goal is to see which method helps remove the cancer completely the first time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a suspected non-melanoma skin cancer lesion that needs to be removed as a day surgery
- The lesion is not in a place where a dermoscope cannot reach
- You are not having a biopsy (incisional, punch, or shave) — only complete removal is being done
- You are able to give informed consent and agree to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a device called Nevisense that helps doctors check if a suspicious skin spot is a type of skin cancer called keratinocyte cancer (including basal cell carcinoma, squamous cell carcinoma, and related conditions like actinic keratosis). If you have a spot that your doctor is unsure about, this tool may help get a clearer answer.
This study is testing a new, very detailed skin imaging method (super-high magnification dermoscopy) to see if it helps doctors diagnose skin tumors more accurately during routine mole checks. If you are already coming for a skin screening, this might help improve how skin cancers are found.
This trial looks at skin tumors that are not melanoma. It uses a special skin exam (dermoscopy) and a biopsy to understand these tumors better. You may join if you have already had these tests and have a confirmed diagnosis.
This study tests a device that takes a close-up picture of a suspicious mole to estimate how deep the melanoma is before surgery. This might help doctors plan surgery more accurately.
This study is testing a handheld device that scans skin lesions to help detect melanoma. If you have a spot that your doctor thinks could be melanoma, this study will see how well the device works compared to standard checks.
This trial tests two methods of checking removed melanoma tissue to see which gives clearer results. It may help improve how doctors determine if all cancer was removed.
Hear when a new Keratinocyte Skin Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.